Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 82   

Articles published

ARNA 4.04 +0.07 (1.76%)
price chart
Will Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Surprise This Quarter?
Most recently for the quarter ending on 2015-03-31, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) posted a surprise factor of 28.57%.
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Sees Large Outflow of Money  OTC Outlook
Arena Pharmaceuticals Rating Increased to Hold at Zacks (ARNA)
Arena Pharmaceuticals (NASDAQ:ARNA) traded up 1.51% on Wednesday, reaching $4.03. The company's stock had a trading volume of 347,726 shares.
Arena Pharmaceuticals, (NASDAQ:ARNA), TrueCar (NASDAQ:TRUE),Iron Mountain ...  JBH News
Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells ...
Arena Pharmaceuticals Inc.'s shares have lost 7.37% in the last one month and 6.53% in the previous three months. However, the stock has gained 19.60% on YTD basis.
Company Shares of Arena Pharmaceuticals, Inc. Rally 1.14%
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) rose by 1.14% in the past week and 1.83% for the last 4 weeks. In the past week, the shares has outperformed the S&P 500 by 2.34% and the outperformance increases to 2.62% for the last 4 weeks.
Company Shares of Arena Pharmaceuticals, Inc. Rally 4.9%
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) rose by 4.9% in the past week and 1.81% for the last 4 weeks. In the past week, the shares have outperformed the S&P 500 by 2.43% and the outperformance increases to 1.01% for the last 4 weeks.
Mid-Morning Market Update: Markets Mostly Higher; Bank Of America Tops Q2 Views
... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), up 10 percent, and Celgene Corporation (NASDAQ: CELG), up 9 percent.
Healthcare Bulls In Short Run: Celgene Corporation (NASDAQ:CELG), Arena ...  Stock Transcript
4 Stocks in Focus - Bank of America Corp (BAC), U.S. Bancorp (USB), Arena ...  Investor Wired
Ratings Watch - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) have been given a consensus rating of 2.5 by brokerage analysts covering the stock.
Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and ...
SAN DIEGO, July 30, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it will host a conference call and webcast at 5:00 p.m.
Notable Session Mover: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
A notable mover in today's trading session is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) as the stock opened the most recent session at 4.33 and at the time of writing the last Bid was at 4.25.
Biotech Stocks To Love - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Novavax ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) gained +1.82% to close last trading session at $4.47. The company, on June 16, 2015, announced that Robert E. Hoffman, Senior Vice President, Finance and Chief Financial Officer, has decided to leave the ...